amyloid-beta

Documents about amyloid-beta

• Sleep Quality and Amyloid-Beta Kinetics#908897ClinicalTrials.gov
• Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease#273346Europe PMC
• Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients#837699ClinicalTrials.gov
• Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults#824193Research Online
• A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity#630265HAL (France)
• Natural History of Amyloid Deposition in Adults With Down Syndrome#811102ClinicalTrials.gov
• Study of AV-1959D, an Amyloid Beta Vaccine#628588ClinicalTrials.gov
• Sleep fragmentation correlates with amyloid beta deposition at brain autopsy.#312353NCBI PubMed Central
• Spearmint extract Neumentix downregulates amyloid-β accumulation by promoting phagocytosis in APP23 mice#194771OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Microglial Clearance of Alzheimer's Amyloid-Beta Obstructed by Nanoplastics.#247834NCBI PubMed Central
• Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation#869338ClinicalTrials.gov
• Progress in (Photo)electrochemical Biosensors for the Detection of Amyloid-Beta Oligomer.#315411NCBI PubMed Central
• Cellular- and systems-level profiling of amyloid-beta effects on circadian timing.#375240NCBI PubMed Central
• Detecting Beta-amyloid in the Retina#851268ClinicalTrials.gov
• Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl#855748ClinicalTrials.gov
• Ion-Mediated adsorption of amyloid‑β peptides at the liquid/liquid interface: insights from electrochemistry and molecular dynamics simulations#470057ULRR
• Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection.#209646NCBI PubMed Central
• Home-based Cognitive Monitoring in MCI#825923ClinicalTrials.gov
• Cocoa supplementation reduces amyloid-beta_1-42(Aβ_1-42) induced deficits in a transgenic <i>C. elegans</i>#624500Figshare
• Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)#865362ClinicalTrials.gov
• Analyses de biomarqueurs de la maladie d’Alzheimer par Désorption/Ionisation Laser Assistée par Surface (SALDI)#291804HAL (France)
• Propionate Decreases Microglial Activation but Impairs Phagocytic Capacity in Response to Aggregated Fibrillar Amyloid Beta Protein.#152148NCBI PubMed Central
• Amyloid-beta glycation induces neuronal mitochondrial dysfunction and Alzheimer's pathogenesis via VDAC1-dependent mtDNA efflux.#193369NCBI PubMed Central
• Cross-Modal Knowledge Distillation for PET-Free Amyloid-Beta Detection from MRI#322198DORAS
• Amyloid beta exacerbates Tau-seeded pathology and drives tangle formation in human neuronal xenografts#387654Europe PMC
• PET Imaging of Brain Amyloid Using [11C]MeS-IMPY#908589ClinicalTrials.gov
• Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review#5490Europe PMC
• Residue-specific binding of Ni(II) ions influences the structure and aggregation of amyloid beta (Aβ) peptides#225026Ora Oxford University Research
• Escin Attenuates Amyloid Beta 1-42-Induced Oxidative Stress, Apoptosis, and Neuroinflammation in Neuron-Like SH-SY5Y Cells.#189934NCBI PubMed Central
• Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study.#220854NCBI PubMed Central
• Computational Nanobody Design for Oligomeric Amyloid-beta#673222İzmir Yüksek Teknoloji Enstitüsü
• Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease#858817ClinicalTrials.gov
• Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids#804025ClinicalTrials.gov
• The role of diet in moderating the relationship between symptoms of depression and brain amyloid load#977237Research Online
• lncRNAs: key player in Aβ deposition#4583Europe PMC
• Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.#18484NCBI PubMed Central
• Amyloid-beta statuses prediction with free water MR imaging features in Alzheimer's disease using machine learning models.#148241NCBI PubMed Central
• Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory#860263ClinicalTrials.gov
• Zn impacts Cu coordination to amyloid-beta, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity#427236HAL Science
• Sleep Fragmentation and Sleep Stages 1 and 2 Are Associated With Amyloid-Beta Burden in Cognitively Normal Older Adults.#255450NCBI PubMed Central
• The Associations of Cerebral Blood Flow and White Matter Hyperintensities with Tau and Amyloid-beta Across the Alzheimer's Disease Spectrum#310942bioRxiv / medRxiv
• A high-throughput assay for monitoring and quantifying amyloid-β accumulation and clearance in Alzheimer's disease cell models#299040Research Online
• Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibition#657789Cornell eCommons
• Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.#154197NCBI PubMed Central
• The impact of cognitive behavioral therapy for insomnia on cognitive performance and amyloid beta in older adults: A randomized controlled trial.#284877NCBI PubMed Central
• Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.#659518NCBI PubMed Central
• Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease#911430ClinicalTrials.gov
• Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia#882452ClinicalTrials.gov
• Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer's disease#205460Europe PMC
• Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition#966310ClinicalTrials.gov